We are live on
!
Find out more
YIH
Y-Intercept (HK) Portfolio holdings
AUM
$5.05B
1-Year Est. Return
17.89%
This Fund
S&P 500
This Quarter
Est. Return
-6.93%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
–
AUM
$1,000M
AUM Growth
+$239M
(+31%)
Cap. Flow
+$349M
Cap. Flow
% of AUM
34.94%
Top 10 Holdings %
Top 10 Hldgs %
8.93%
Holding
1,387
New
562
Increased
225
Reduced
140
Closed
460
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$12M |
| 2 |
Verizon
VZ
|
+$11.7M |
| 3 |
Comcast
CMCSA
|
+$10.3M |
| 4 |
Procter & Gamble
PG
|
+$7.96M |
| 5 |
Liberty Broadband Class C
LBRDK
|
+$6.85M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marathon Petroleum
MPC
|
+$8.93M |
| 2 |
Amgen
AMGN
|
+$5.81M |
| 3 |
ConocoPhillips
COP
|
+$5.66M |
| 4 |
Illumina
ILMN
|
+$5.4M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$5.32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.44% |
| 2 | Consumer Discretionary | 11.9% |
| 3 | Financials | 11.76% |
| 4 | Industrials | 10.6% |
| 5 | Healthcare | 9.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
TG Therapeutics
TGTX
$8.53B
| $197K | 0.02% |
+33,234
| New | +$218K |
|
|
LBAI
827
DELISTED
Lakeland Bancorp Inc
LBAI
| $195K | 0.02% |
+12,150
| New | +$194K |
|
|
ALBO
828
DELISTED
Albireo Pharma Inc
ALBO
| $194K | 0.02% |
+10,010
| New | +$207K |
|
829
B&G Foods
BGS
$299M
| $191K | 0.02% |
+11,592
| New | +$257K |
|
|
SAFE
830
Safehold
SAFE
$1.2B
| $191K | 0.02% |
+4,232
| New | +$294K |
|
831
Old National Bancorp
ONB
$10.2B
| $187K | 0.02% |
+11,357
| New | +$190K |
|
832
Array Technologies
ARRY
$780M
| $186K | 0.02% |
11,191
-4,038
| -27% | -$69.8K |
|
|
MOMO
833
Hello Group
MOMO
$869M
| $184K | 0.02% |
39,774
+24,498
| +160% | +$117K |
|
834
Robinhood
HOOD
$83.9B
| $183K | 0.02% |
+18,071
| New | +$174K |
|
|
CLDT
835
Chatham Lodging
CLDT
$630M
| $181K | 0.02% |
+18,317
| New | +$220K |
|
|
SIX
836
DELISTED
Six Flags Entertainment Corp.
SIX
| $180K | 0.02% |
10,192
-14,607
| -59% | -$330K |
|
837
Protagonist Therapeutics
PTGX
$8.74B
| $180K | 0.02% |
+21,395
| New | +$202K |
|
838
Repay Holdings
RPAY
$339M
| $178K | 0.02% |
+25,231
| New | +$275K |
|
839
Sixth Street Specialty
TSLX
$1.68B
| $173K | 0.02% |
10,605
-6,933
| -40% | -$129K |
|
|
RNAM
840
DELISTED
Avidity Biosciences
RNAM
| $172K | 0.02% |
+10,539
| New | +$202K |
|
841
Cenovus Energy
CVE
$51.4B
| $172K | 0.02% |
11,197
-70,060
| -86% | -$1.24M |
|
842
MBIA
MBI
$277M
| $171K | 0.02% |
+18,603
| New | +$221K |
|
843
Magnachip Semiconductor
MX
$118M
| $170K | 0.02% |
+16,567
| New | +$217K |
|
844
ProFrac Holding
ACDC
$693M
| $166K | 0.02% |
+10,883
| New | +$196K |
|
845
Upland Software
UPLD
$14.7M
| $164K | 0.02% |
+2,020
| New | +$224K |
|
846
Quanterix
QTRX
$168M
| $163K | 0.02% |
+14,756
| New | +$188K |
|
847
CION Investment
CION
$303M
| $156K | 0.02% |
+18,383
| New | +$173K |
|
|
TPIC
848
DELISTED
TPI Composites
TPIC
| $156K | 0.02% |
+13,844
| New | +$219K |
|
849
Zymeworks
ZYME
$1.67B
| $156K | 0.02% |
+25,374
| New | +$153K |
|
850
Praxis Precision Medicines
PRAX
$8.16B
| $156K | 0.02% |
+4,567
| New | +$228K |
|
Similar funds
HSA
O
LIM
LFG
JIM
CTC
NL
BPWM
Y-Intercept (HK)'s Q3 2022 Portfolio in Review
As of Q3 2022, Y-Intercept (HK) held 1,387 positions worth $1,000M, up 31% from $761M the previous quarter. Its ten largest holdings account for 8.9% of the portfolio.
Y-Intercept (HK) deployed $349M of net new capital in Q3 2022, opening 562 new positions and adding to 225 existing holdings. Its largest new stake was Chevron: 78,786 shares worth $11.3M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Marathon Petroleum, an estimated $8.93M trimmed.
- Y-Intercept (HK)'s largest Q3 2022 buy was Chevron: 78,786 shares worth $11.3M.
- Y-Intercept (HK) added most to Comcast in Q3 2022, an estimated $10.3M increase.
- Y-Intercept (HK)'s biggest Q3 2022 reduction was Marathon Petroleum, cutting an estimated $8.93M.
- Y-Intercept (HK) fully exited Amgen in Q3 2022, selling an estimated $5.81M.
- Y-Intercept (HK)'s ten largest holdings make up 8.9% of its $1,000M portfolio in Q3 2022.
- Y-Intercept (HK) opened 562 new positions and closed 460 in Q3 2022.
- Y-Intercept (HK)'s portfolio value rose 31% quarter-over-quarter to $1,000M.
Based on Y-Intercept (HK)'s 13F filing for Q3 2022, filed 14 Feb 2023.